-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Aytu Biopharma, Inc quarterly/annual Depreciation history and growth rate from 2011 to 2024.
- Aytu Biopharma, Inc Depreciation for the quarter ending June 30, 2024 was $100K, a 66.7% decline year-over-year.
- Aytu Biopharma, Inc Depreciation for the twelve months ending June 30, 2024 was $900K, a 30.8% decline year-over-year.
- Aytu Biopharma, Inc annual Depreciation for 2024 was $900K, a 30.8% decline from 2023.
- Aytu Biopharma, Inc annual Depreciation for 2023 was $1.3M, a 18.8% decline from 2022.
- Aytu Biopharma, Inc annual Depreciation for 2022 was $1.6M, a 167% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)